Treatment with Statins in High-Risk Patients: Relevance of Time to Titration of Dose and Adverse Outcomes

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.9, Iss.3, 2009-05, pp. : 211-212

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Time to Titration to Maximum Dose of Statins on Cardiovascular Outcomes: A Retrospective Analysis in High-Risk Patients

By Friend Amy S.

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 2, 2009-01 ,pp. : 103-107

Adis International

Access to resources Recommend Favorite

High dose statins reduce myocardial compromise and improve cardiac outcomes in patients undergoing major cardiac surgery

Inpharma, Vol. 1, Iss. 1611, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

High-dose lisinopril feasible in high-risk patients with HF

Inpharma, Vol. 1, Iss. 1271, 2001-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Ramipril: A Review of its Use in Preventing Cardiovascular Outcomes in High-Risk Patients

By Anderson Vanessa R. Perry Caroline M. Robinson Dean M.

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 6, 2006-01 ,pp. : 417-432

Adis International

Access to resources Recommend Favorite

ATP III update targets high-risk patients, statins market to benefit?

Inpharma, Vol. 1, Iss. 1447, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite